Counsyl, maker of DNA tests used to diagnose predispositions to genetic diseases in prospective parents before they conceive, has brought in $2.2 million in equity, according to a filing with the SEC. Based in Redwood City, Calif., the company raised $2.7 million in 2009 from 21 undisclosed investors. The company got a write-up in The New York Times at the end of January.
Daily insights on business use cases with VB Daily
If you want to impress your boss, VB Daily has you covered. We give you the inside scoop on what companies are doing with generative AI, from regulatory shifts to practical deployments, so you can share insights for maximum ROI.
Read our Privacy Policy
Thanks for subscribing. Check out more VB newsletters here.
An error occured.
